期刊文献+
共找到11,374篇文章
< 1 2 250 >
每页显示 20 50 100
异丙托溴铵联合沙丁胺醇及布地奈德雾化吸入治疗小儿毛细支气管炎疗效观察 被引量:56
1
作者 李延琪 王立军 《儿科药学杂志》 CAS 2013年第3期12-14,共3页
目的:观察异丙托溴铵联合沙丁胺醇及布地奈德雾化吸入治疗小儿毛细支气管炎的临床疗效。方法:将120例毛细支气管炎患儿随机分为治疗组62例和对照组58例,两组均给予对症支持治疗,治疗组在此基础上加用异丙托溴铵联合沙丁胺醇及布地奈德... 目的:观察异丙托溴铵联合沙丁胺醇及布地奈德雾化吸入治疗小儿毛细支气管炎的临床疗效。方法:将120例毛细支气管炎患儿随机分为治疗组62例和对照组58例,两组均给予对症支持治疗,治疗组在此基础上加用异丙托溴铵联合沙丁胺醇及布地奈德雾化吸入治疗,对照组加用沙丁胺醇及布地奈德雾化吸入治疗。观察两组患儿用药后症状缓解情况、肺部哮鸣音减少或消失时间及住院时间,比较两组疗效。结果:治疗后两组患儿临床症状及体征均有不同程度改善;治疗组在喘息、呼吸困难、肺部哮鸣音持续时间以及住院时间方面均短于对照组(P<0.05);治疗组总有效率98.39%,高于对照组的86.21%(P<0.05)。结论:异丙托溴铵联合沙丁胺醇及布地奈德雾化吸入治疗能提高小儿毛细支气管炎患儿的治愈率,缩短疗程。 展开更多
关键词 毛细支气管炎 异丙托溴铵 沙丁胺醇 布地奈德 雾化吸入
下载PDF
糖皮质激素对哮喘患儿的临床疗效及作用机制研究 被引量:42
2
作者 彭芬 黄华 钱炜 《中国临床药理学杂志》 CAS CSCD 北大核心 2016年第1期3-5,共3页
目的探讨吸入型糖皮质激素对哮喘患儿的临床疗效及作用机制。方法 90例哮喘患儿随机分为试验组与对照组,各45例。对照组给予常规治疗,试验组在常规治疗基础上给予吸入型糖皮质激素治疗,5岁以下患儿给予丙酸氟替卡松气雾剂100.0~250.0μg... 目的探讨吸入型糖皮质激素对哮喘患儿的临床疗效及作用机制。方法 90例哮喘患儿随机分为试验组与对照组,各45例。对照组给予常规治疗,试验组在常规治疗基础上给予吸入型糖皮质激素治疗,5岁以下患儿给予丙酸氟替卡松气雾剂100.0~250.0μg·d^(-1)雾化治疗,每天2次;5岁以上患儿给予布地奈德气雾剂200.0~400.0μg·d^(-1)雾化治疗,每天2次。连续治疗4周,观察2组患儿的临床疗效和血清神经营养素-3、外周血嗜酸性粒细胞的变化。结果试验组总有效率为95.56%,对照组总有效率为71.11%,试验组显著优于对照组(P<0.05)。治疗后,试验组与对照组血清神经营养素-3和外周血嗜酸性粒细胞较治疗前显著降低,试验组降低程度较对照组更显著(P<0.05)。结论哮喘患儿治疗的过程中加用糖皮质激素能提高临床疗效,其机制可能是降清血清神经营养素-3和外周血嗜酸性粒细胞计数,控制气道炎症反应。 展开更多
关键词 小儿哮喘 吸入型 糖皮质激素 神经营养素-3 嗜酸性粒细胞
原文传递
重庆地区1105例变应性疾病患儿吸入性变应原临床分析 被引量:19
3
作者 徐文飞 刘恩梅 +5 位作者 周燕荣 彭斌 黄英 陈坤华 蒋永惠 李素碧 《实用儿科临床杂志》 CAS CSCD 北大核心 2008年第9期654-656,共3页
目的探讨重庆地区吸入性变应原的分布情况及其与儿童哮喘发生之间的关系。方法选择室内尘螨、花粉、真菌、蟑螂等13种常见的吸入性变应原,对重庆医科大学附属儿童医院2005年5月-2007年1月共1105例患儿行皮肤点刺试验(SPT),计算各种变应... 目的探讨重庆地区吸入性变应原的分布情况及其与儿童哮喘发生之间的关系。方法选择室内尘螨、花粉、真菌、蟑螂等13种常见的吸入性变应原,对重庆医科大学附属儿童医院2005年5月-2007年1月共1105例患儿行皮肤点刺试验(SPT),计算各种变应原阳性率,并对吸入组变应原皮试结果进行统计,采用SAS8.1软件对数据进行聚类分析,进行单因素、多因素Logistic回归分析。结果被检查的1105例患儿中SPT阳性者893例,占80.81%(893/1105例)。其中,阳性率在50%以上的吸入性变应原有:粉尘螨760例,占68.80%(760/1105例);屋尘螨759例,占68.72%(759/1105例);热带螨594例,占53.08%(594/1105例),其他吸入性变应原阳性率均在15%以下。聚类分析将13种变应原聚为4大类,提示各类内具有某种相似性。以变应原为自变量,哮喘为应变量的单因素Logistic回归分析结果显示,粉尘螨、屋尘螨、热带螨、美洲大蠊这4种变应原可能与哮喘的发病有关;多因素Logistic回归分析结果显示,诸多变应原共同作用时,粉尘螨和热带螨对哮喘的发病有意义;不同年龄和性别对这13种吸入性变应原的过敏程度均有显著性差异(Pa<0.05)。结论螨类为重庆地区哮喘患儿最常见的变应原,且与哮喘的发生关系极为密切。不同性别和年龄对吸入性变应原的过敏程度不同。 展开更多
关键词 变应原 吸入性 哮喘 聚类分析
下载PDF
布地奈德治疗小儿肺炎支原体肺炎的效果及其对免疫球蛋白水平的影响 被引量:17
4
作者 施璐 李红叶 王凤圈 《保健医学研究与实践》 2017年第1期48-50,共3页
目的探讨布地奈德雾化吸入对肺炎支原体肺炎患儿的治疗效果及其对免疫球蛋白水平的影响。方法选取驻马店市某医院2013年1月-2015年1月收治的84例肺炎支原体肺炎患儿为研究对象,随机分为观察组与对照组,每组42例。对照组患儿静脉滴注阿... 目的探讨布地奈德雾化吸入对肺炎支原体肺炎患儿的治疗效果及其对免疫球蛋白水平的影响。方法选取驻马店市某医院2013年1月-2015年1月收治的84例肺炎支原体肺炎患儿为研究对象,随机分为观察组与对照组,每组42例。对照组患儿静脉滴注阿奇霉素进行治疗,观察组患儿在对照组基础上加用布地奈德雾化吸入进行治疗,比较2组患儿治疗总有效率及治疗前后2组患儿的血清免疫球蛋白(IgG,IgM,IgA)水平。结果观察组患儿治疗总有效率高于对照组,差异有统计学意义(P<0.05)。治疗前,2组患儿血清IgG,IgM,IgA水平差异无统计学意义(P>0.05);治疗后,2组患儿IgG,IgA水平低于治疗前,差异有统计学意义(P<0.05),且观察组患儿IgG,IgA水平均低于对照组,差异有统计学意义(P<0.05)。结论静脉滴注阿奇霉素联合布地奈德雾化吸入治疗小儿肺炎支原体肺炎效果显著,且能改善患儿血清免疫球蛋白水平,值得临床推广应用。 展开更多
关键词 布地奈德 雾化吸入 肺炎支原体肺炎患儿 体液免疫功能
下载PDF
A Time Series Observation of Chinese Children Undergoing Rigid Bronchoscopy for an Inhaled Foreign Body: 3149 Cases in 1991-2010 被引量:14
5
作者 Xu Zhang Wen-Xian Li Yi-Rong Cai 《Chinese Medical Journal》 SCIE CAS CSCD 2015年第4期504-509,共6页
Background:In China,tracheobronchial foreign body (TFB) aspiration,a major cause of emergency episode and accident death in children,remains a challenge for anesthetic management.Here,we share our experience and di... Background:In China,tracheobronchial foreign body (TFB) aspiration,a major cause of emergency episode and accident death in children,remains a challenge for anesthetic management.Here,we share our experience and discuss the anesthetic consideration and management of patients with TFB aspiration.Methods:This was a single-institution retrospective study in children with an inhaled foreign body between 1991 and 2010 that focused on the complications following rigid bronchoscopy (RB).Data including the clinical characteristics of patients and TFB,anesthetic method,and postoperative severe complications were analyzed by different periods.Results:During the 20-year study period,the charts of 3149 patients who underwent RB for suspected inhaled TFB were reviewed.There were 2079 male and 1070 female patients (1.94:1).A nut (84%) was the most commonly inhaled object.The study revealed a 9% (n =284) overall rate of severe postoperative complications related to severe hypoxemia,laryngeal edema,complete laryngospasm,pneumothorax,total segmental atelectasis,and death with incidences of 3.2%,0.9%,1.3%,0.3%,0.3%,and 0.1%,respectively.The rates of preoperative airway impairment,negative findings of TFB,and adverse postoperative events have been on the rise in the past 5 years.Conclusions:The survey results confirmed that hypoxemia remains the most common postoperative complication in different periods.Both controlled ventilation and spontaneous ventilation were effective during the RB extraction of the foreign body at our hospital in the modern technique period.An active respiratory symptom was commonly seen in the groups with negative findings. 展开更多
关键词 COMPLICATION inhaled Foreign Body Rigid Bronchoscope
原文传递
噻托溴铵治疗稳定期慢性阻塞性肺疾病的疗效评价 被引量:16
6
作者 冯玉麟 邱婷 唐永江 《世界临床药物》 CAS 2009年第1期15-19,26,共6页
噻托溴铵是新一代治疗慢性阻塞性肺疾病(COPD)的吸入型长效抗胆碱药物,通过选择性作用于M1和M3受体,扩张支气管,疗效持续,每天只需使用一次。UPLIFT研究结果进一步证实,长期规律使用噻托溴铵能够改善中重度、极重度稳定期COPD患者肺功... 噻托溴铵是新一代治疗慢性阻塞性肺疾病(COPD)的吸入型长效抗胆碱药物,通过选择性作用于M1和M3受体,扩张支气管,疗效持续,每天只需使用一次。UPLIFT研究结果进一步证实,长期规律使用噻托溴铵能够改善中重度、极重度稳定期COPD患者肺功能情况,缓解症状、提高运动耐量及改善生活质量,延长急性发作的时间间隔、减少急性加重发作次数,降低COPD患者死亡率,具有良好的安全性。 展开更多
关键词 噻托溴铵 抗胆碱药物 吸入制剂 慢性阻塞性肺疾病 UPLIFT研究
下载PDF
Agglomeration rate and action forces between atomized particles of agglomerator and inhaled-particles from coal combustion 被引量:12
7
作者 WEIFeng ZHANGJun-ying ZHENGChu-guang 《Journal of Environmental Sciences》 SCIE EI CAS CSCD 2005年第2期335-339,共5页
In order to remove efficiently haled-particles emissions from coal combustions, a new way was used to put forward the process of agglomeration and the atomization was produced by the nozzle and then sprayed into the ... In order to remove efficiently haled-particles emissions from coal combustions, a new way was used to put forward the process of agglomeration and the atomization was produced by the nozzle and then sprayed into the flue before precipitation devices of power station boiler in order to make inhaled-particles agglomerate into bigger particles, which can be easily removed but not change existing running conditions of boiler. According to this idea, a model is set up to study agglomeration rate and effect forces between fly ash inhaled-particles and atomized agglomerator particles. The developed agglomeration rate was expressed by relative particle number decreasing speed per unit volume. The result showed that viscosity force and flow resistance force give main influences on agglomeration effect of inhaled-particles, while springiness force and gravity have little effect on agglomeration effect of theirs. Factors influencing the agglomeration rate and effect forces are studied, including agglomerator concentration, agglomerator flux and agglomerator density, atomized-particles diameters and inhaled-particles diameter and so on. 展开更多
关键词 inhaled particles agglomerator effect forces agglomeration rate
下载PDF
联合吸入噻托溴铵和布地奈德混悬液治疗COPD的疗效观察 被引量:12
8
作者 王志新 陈宏民 乔红伟 《临床肺科杂志》 2010年第5期629-630,共2页
目的观察联合吸入噻托溴铵及布地奈德混悬液治疗COPD。方法呼吸内科住院COPD患者60例,(男42例,女18例),按照随机数字表法分为三组:(1)联合治疗组20例,吸入噻托溴铵干粉胶囊1粒(18μg),经单剂量干粉吸入器,每日上午1次,吸入布地奈德混悬... 目的观察联合吸入噻托溴铵及布地奈德混悬液治疗COPD。方法呼吸内科住院COPD患者60例,(男42例,女18例),按照随机数字表法分为三组:(1)联合治疗组20例,吸入噻托溴铵干粉胶囊1粒(18μg),经单剂量干粉吸入器,每日上午1次,吸入布地奈德混悬液,通过DRT型小型雾化器,剂量每次1 mg,1天2次。(2)布地奈德雾化液吸入组,20例,吸入布地奈德混悬液,剂量每次1 mg,1天2次。(3)空白对照组20例,疗程2周。结果试验组在第一周以后,吸入沙丁胺醇前的FEV1均明显高于空白对照组,一直持续到第二周,联合治疗组的FEV1升高明显高于布地奈德组。实验结束时,联合治疗组的FEV1提高了10.3%,布地奈德组提高了8.2%。空白对照组改变不明显。差异均有统计学意义。结论吸入型长效抗胆碱能药物联合长效激素制剂治疗COPD,在控制症状、改善肺功能方面均优于单独使用激素,及空白对照组。本试验未发现有更多的不良反应,其安全性能够被接受。 展开更多
关键词 肺疾病 慢性阻塞性 长效抗胆碱能药物 长效激素制剂 吸入型
下载PDF
Effect of Inhaled Budesonide on Interleukin-4 and Interleukin-6 in Exhaled Breath Condensate of Asthmatic Patients 被引量:7
9
作者 Chun-Hua Chi Ji-Ping Liao +2 位作者 Yan-Ni Zhao Xue-Ying Li Guang-Fa Wang 《Chinese Medical Journal》 SCIE CAS CSCD 2016年第7期819-823,共5页
Background: Studies of interleukin (IL)-4 and IL-6 in the exhaled breath condensate (EBC) of asthmatic patients are limited. This study was to determine the effect of inhaled corticosteroid (ICS) treatment on I... Background: Studies of interleukin (IL)-4 and IL-6 in the exhaled breath condensate (EBC) of asthmatic patients are limited. This study was to determine the effect of inhaled corticosteroid (ICS) treatment on IL-4 and IL-6 in the EBC &asthmatic patients. Methods: In a prospective, open-label study, budesonide 200 μg twice daily by dry powder inhaler was administered to 23 adult patients with uncontrolled asthma (mean age 42.7 years) for 12 weeks. Changes in asthma scores, lung function parameters (forced expiratory volume in 1 s [FEV1], peak expiratory flow [PEF], forced expiratory flow at 50% of forced vital capacity [FEFs0], forced expiratory flow at 75% of forced vital capacity, maximum mid-expiratory flow rate) and the concentrations of IL-4 and IL-6 in EBC were measured. Results: Both asthma scores and lung function parameters were significantly improved by ICS treatment. The mean IL-4 concentration in the EBC was decreased gradually, from 1.92 ± 0.56 pmol/L before treatment to 1.60 ± 0.36 pmolJL after 8 weeks of treatment (P 〈 0.05) and 1.54 ± 0.81 pmol/L after 12 weeks of treatment (P 〈 0.01). However, the IL-6 concentration was not significantly decreased. The change in the IL-4 concentration was correlated with improvements in mean FEVt, PEF and FEFso values (correlation coefficients -0.468, -0.478, and -0.426, respectively). Conclusions: The concentration of IL-4 in the EBC of asthmatic patients decreased gradually with ICS treatment. Measurement of IL-4 in EBC could be useful to monitor airway inflammation in asthmatics. 展开更多
关键词 ASTHMA Exhaled Breath Condensate inhaled Corticosteroids INTERLEUKIN-4 INTERLEUKIN-6
原文传递
吸入糖皮质激素治疗支气管哮喘的研究进展 被引量:9
10
作者 张志智 卢添宝 《湖州师范学院学报》 2005年第1期112-115,共4页
通过对近年来吸入糖皮质激素治疗支气管哮喘的研究综述,了解吸入糖皮质激素对于预防或减少支气管哮喘反复急性发作、保护肺功能、提高生活质量的重要性,从而进一步推广吸入糖皮质激素疗法,使其成为防治哮喘的主要方法.
关键词 吸入 激素 哮喘 进展
下载PDF
针刺辅助麻醉对妇科腹腔镜手术患者MAC的影响 被引量:7
11
作者 尹利华 李万山 +2 位作者 招伟贤 李万瑶 陈志雄 《新中医》 CAS 北大核心 2002年第4期47-48,共2页
目的:将针刺辅助全身麻醉用于妇科腹腔镜手术,观察针刺麻醉的镇痛效能。方法:36例腹腔镜手术患者随机分为Ⅰ组(单纯全身麻醉组)和Ⅱ组(针刺辅助全身麻醉组),记录术中呼出末全麻药最低肺泡内有效浓度(MAC),观察-2组结... 目的:将针刺辅助全身麻醉用于妇科腹腔镜手术,观察针刺麻醉的镇痛效能。方法:36例腹腔镜手术患者随机分为Ⅰ组(单纯全身麻醉组)和Ⅱ组(针刺辅助全身麻醉组),记录术中呼出末全麻药最低肺泡内有效浓度(MAC),观察-2组结果的差异。结果:Ⅰ组中MAC平均值为(1.65±0.27)Vol%,Ⅱ组中MAC平均值为(1.34±0.24)Vol%,针刺辅助麻醉能降低MAC约18.18%,2组比较,差异有非常显著性意义(P<0.01)。结论:针刺辅助全身麻醉所需的麻醉浓度低于单纯全身麻醉,针刺麻醉具有一定的麻醉镇痛辅助作用,值得在临床上推广应用。 展开更多
关键词 针药复合麻醉 麻醉吸入 最低肺泡内有浓度 腹腔镜手术 妇科腹腔镜手术
下载PDF
Do inhaled corticosteroids increase the risk of Pneumocystis pneumonia in people with lung cancer? 被引量:5
12
作者 Sameh Msaad Ilhem Yangui +5 位作者 Najla Bahloul Narjes Abid Makram Koubaa Yosr Hentati Mounir Ben Jemaa Samy Kammoun 《World Journal of Clinical Cases》 SCIE 2015年第9期843-847,共5页
Pneumocystis pneumonia(PCP) is a life-threatening infection in immunocompromised patients. It is relatively uncommon in patients with lung cancer. We report a case of PCP in a 59-year-old man with a past medical histo... Pneumocystis pneumonia(PCP) is a life-threatening infection in immunocompromised patients. It is relatively uncommon in patients with lung cancer. We report a case of PCP in a 59-year-old man with a past medical history of chronic obstructive pulmonary disease treated with formoterol and a moderate daily dose of inhaled budesonide. He had also advanced stage non-small lung cancer treated with concurrent chemo-radiation with a cisplatin-etoposide containing regimen. The diagnosis of PCP was suspected based on the context of rapidly increasing dyspnea, lymphopenia and the imaging findings. Polymerase chain reaction testing on an induced sputum specimen was positive for Pneumocystis jirovecii. The patient was treated with oral trimethoprim-sulfamethoxazole and systemic corticotherapy and had showed clinical and radiological improvement. Six months after the PCP diagnosis, he developed a malignant pleural effusion and expired on hospice care. Through this case, we remind the importance of screening for PCP in lung cancer patients under chemotherapeutic regimens and with increasing dyspnea. In addition, we alert to the fact that long-term inhaled corticosteroids may be a risk factor for PCP in patients with lung cancer. Despite intensive treatment, the mortality of PCP remains high, hence the importance of chemoprophylaxis should be considered. 展开更多
关键词 PNEUMOCYSTIS jiroveci Lung NEOPLASMS PNEUMONIA inhaled CORTICOSTEROIDS PROPHYLAXIS
下载PDF
吸入型糖皮质激素对哮喘患儿NT-3和EOS水平的影响 被引量:7
13
作者 李湘津 颜娟 刘丽君 《中国临床研究》 CAS 2018年第5期627-629,共3页
目的探讨吸入型糖皮质激素对哮喘患儿的临床疗效及对血清神经营养素-3(NT-3)、外周血嗜酸性粒细胞(EOS)的影响及相关机制。方法选择2015年3月至2016年6月兰州大学第一医院收治的120例哮喘患儿作为研究对象,按随机数字表法将患儿分为研... 目的探讨吸入型糖皮质激素对哮喘患儿的临床疗效及对血清神经营养素-3(NT-3)、外周血嗜酸性粒细胞(EOS)的影响及相关机制。方法选择2015年3月至2016年6月兰州大学第一医院收治的120例哮喘患儿作为研究对象,按随机数字表法将患儿分为研究组和对照组,各60例。对照组给予常规治疗,研究组在常规治疗基础上给予吸入型糖皮质激素治疗。连续治疗4周,观察两组患儿的临床疗效和血清NT-3、外周血EOS计数的变化。结果研究组总有效率显著高于对照组,差异有统计学意义(93.33%vs 71.67%,χ2=9.755,P<0.01);研究组与对照组治疗前血清NT-3水平[(55.98±13.45)ng/ml vs(55.98±13.45)ng/ml]和外周血EOS计数[(0.45±0.12)×109/L vs(0.42±0.13)×109/L]差异无统计学意义(P均>0.05);治疗2周后,研究组与对照组血清NT-3[(24.34±8.05)ng/ml、(34.56±9.87)ng/ml]和外周血EOS计数[(0.13±0.02)×109/L、(0.33±0.04)×109/L]较治疗前显著降低,且研究组低于对照组(P均<0.01)。结论哮喘患儿治疗的过程中加用糖皮质激素能提高临床疗效,其机制可能是降清血清NT-3水平和外周血EOS计数,控制气道炎症反应。 展开更多
关键词 小儿哮喘 糖皮质激素 吸入型 神经营养素-3 嗜酸性粒细胞
原文传递
萘丸吸入毒性研究 被引量:6
14
作者 王献仁 尹先仁 +1 位作者 郭润荣 张丽霞 《环境与健康杂志》 CAS CSSCI CSCD 北大核心 1995年第2期67-68,共2页
本文用大鼠对萘丸进行了为期90天、每天染毒7小时的吸入毒性研究。结果表明,萘丸可导致动物血象(RBC、WBC及其分类)改变和肝脏肿大。长期吸入含萘空气对机体有一定危害。
关键词 毒性 毒理学
下载PDF
Pharmacological therapy for stable chronic obstructive pulmonary disease 被引量:2
15
作者 Ruirui Duan Baicun Li Ting Yang 《Chronic Diseases and Translational Medicine》 CAS CSCD 2023年第2期82-89,共8页
In recent years,emphasis has shifted from preventing and treating chronic obstructive pulmonary disease(COPD)to early prevention,early treatment,and disease stabilization,with the main goal of improving patients’qual... In recent years,emphasis has shifted from preventing and treating chronic obstructive pulmonary disease(COPD)to early prevention,early treatment,and disease stabilization,with the main goal of improving patients’quality of life and reducing the frequency of acute exacerbations.This review summarizes pharmacological therapies for stable COPD. 展开更多
关键词 BRONCHODILATOR chronic obstructive pulmonary disease inhaled corticosteroid pharmacological therapy
原文传递
布地奈德雾化吸入治疗老年支气管哮喘急性加重期的临床效果 被引量:5
16
作者 陈佳 李生锦 +1 位作者 王娜 余晟岚 《内蒙古中医药》 2013年第8期81-83,共3页
目的:研究不同剂量布地奈德雾化吸入治疗老年支气管哮喘急性加重期的临床效果,以探求一种最有效的使用剂量。方法:临床入选支气管哮喘急性加重期老年患者200例,按照入院先后顺序编号,根据随机数字方法分成4组,每组50例,分别为布地奈德2... 目的:研究不同剂量布地奈德雾化吸入治疗老年支气管哮喘急性加重期的临床效果,以探求一种最有效的使用剂量。方法:临床入选支气管哮喘急性加重期老年患者200例,按照入院先后顺序编号,根据随机数字方法分成4组,每组50例,分别为布地奈德2000μg/d雾化吸入治疗(A组);布地奈德4000μg/d雾化吸入治疗(B组);布地奈德6000μg/d雾化吸入治疗(C组);泼尼松30mg/d口服治疗作为对照组(D组)。比较分析各组患者的相关临床指标。结果:各组治疗4h后的FEV1占预计值的百分比、PEF占预计值的百分比以及临床评分较治疗前明显改善,且均具有统计学差异(P<0.05)。而四组之间的临床评分、FEV1占预计值的百分比以及PEF占预计值的百分比治疗前后的差值均无统计学差异(P>0.05)。治疗7天和21天后,与A组相比较,B组、C组和D组的FEV1占预计值的百分比以及PEF占预计值的百分比的治疗前后差值明显增高(P<0.05);与B组相比较,C组和D组的FEV1占预计值的百分比以及PEF占预计值的百分比的治疗前后差值也明显增高(P<0.05)。结论:雾化吸入布地奈德可以改善患者的肺功能以及临床表现,增大布地奈德混悬液雾化吸入剂量在一定程度上可以提高其疗效,6000μg/d雾化吸入与口服泼尼松30mg/d的疗效相当。 展开更多
关键词 支气管哮喘急性加重期 雾化吸入 糖皮质激素
下载PDF
吸入糖皮质激素对高危哮喘儿预后影响的研究 被引量:5
17
作者 覃敏 《广西医学》 CAS 2005年第11期1726-1728,共3页
目的探讨吸入糖皮质激素对高危哮喘儿预后的影响。方法将80例高危哮喘儿分两组:治疗组吸入糖皮质激素(必可酮),对照组只作一般治疗,未吸入激素,观察1年内两组确诊为哮喘的例数,比较两组间同期患呼吸道感染的人次数和再次住院的人数。结... 目的探讨吸入糖皮质激素对高危哮喘儿预后的影响。方法将80例高危哮喘儿分两组:治疗组吸入糖皮质激素(必可酮),对照组只作一般治疗,未吸入激素,观察1年内两组确诊为哮喘的例数,比较两组间同期患呼吸道感染的人次数和再次住院的人数。结果两组1年内哮喘的发生率比较,治疗组5.3%,对照组30%,两组比较P<0.01;反复患上下呼吸道感染6次以上的人数比例,治疗组12.5%,对照组37.5%,两组比较P<0.01;需要再次住院的人数比例,治疗组5%,对照组45%,两组比较P<0.01。结论高危哮喘儿吸入糖皮质激素可以减少哮喘的发病率,能有效地预防这部分婴幼儿哮喘的发生,同时可以减少这些患儿的呼吸道感染次数,减少他们再次住院的机率,有助于身体的康复。 展开更多
关键词 吸入 糖皮质激素 高危儿童 哮喘
下载PDF
Comparison of inhaled milrinone, nitric oxide and prostacyclin in acute respiratory distress syndrome 被引量:5
18
作者 Martin Albert Daniel Corsilli +5 位作者 David R Williamson Marc Brosseau Patrick Bellemare Stéphane Delisle Anne QN Nguyen France Varin 《World Journal of Critical Care Medicine》 2017年第1期74-78,共5页
AIM To evaluate the safety and efficacy of inhaled milrinone in acute respiratory distress syndrome(ARDS).METHODS Open-label prospective cross-over pilot study where fifteen adult patients with hypoxemic failure meeti... AIM To evaluate the safety and efficacy of inhaled milrinone in acute respiratory distress syndrome(ARDS).METHODS Open-label prospective cross-over pilot study where fifteen adult patients with hypoxemic failure meeting standard ARDS criteria and monitored with a pulmonary artery catheter were recruited in an academic 24-bed medico-surgical intensive care unit. Random sequential administration of i NO(20 ppm) or nebulized epoprostenol(10 μg/mL) was done in all patients. Thereafter, inhaled milrinone(1 mg/mL) alone followed by inhaled milrinone in association with inhaled nitric oxide(iN O) was administered. A jet nebulization device synchronized with the mechanical ventilation was use to administrate the epoprostenol and the milrinone. Hemodynamic measurements and partial pressure of arterial oxygen(PaO_2) were recorded before and after each inhaled therapyadministration.RESULTS The majority of ARDS were of pulmonary cause(n = 13) and pneumonia(n = 7) was the leading underlying initial disease. Other pulmonary causes of ARDS were: Post cardiopulmonary bypass(n = 2), smoke inhalation injury(n = 1), thoracic trauma and pulmonary contusions(n = 2) and aspiration(n = 1). Two patients had an extra pulmonary cause of ARDS: A polytrauma patient and an intra-abdominal abscess Inhaled nitric oxide, epoprostenol, inhaled milrinone and the combination of inhaled milrinone and i NO had no impact on systemic hemodynamics. No significant adverse events related to study medications were observed. The median increase of PaO 2 from baseline was 8.8 mmH g [interquartile range(IQR) = 16.3], 6.0 mm Hg(IQR = 18.4), 6 mm Hg(IQR = 15.8) and 9.2 mm Hg(IQR = 20.2) respectively with i NO, epoprostenol, inhaled milrinone, and i NO added to milrinone. Only i NO and the combination of inhaled milrinone and i NO had a statistically significant effect on PaO 2. CONCLUSION When comparing the effects of inhaled NO, milrinone and epoprostenol, only NO significantly improved oxygenation. Inhaled milrinone appeared safe but failed to improve oxyge 展开更多
关键词 inhaled milrinone Nitric oxide Pulmonary hypertension HYPOXEMIA Acute respiratory distress syndrome PROSTACYCLIN
下载PDF
呼出气一氧化氮及嗜酸粒细胞预测COPD患者吸入型糖皮质激素治疗效果的临床价值 被引量:5
19
作者 李星虹 李振生 +2 位作者 王红景 张乐天 唐茜 《国际呼吸杂志》 2019年第12期916-920,共5页
目的探讨呼出气一氧化氮(FENO)及嗜酸粒细胞(EOS)预测慢性阻塞性肺疾病(COPD)患者吸入型糖皮质激素(ICS)治疗效果的临床价值。方法选取2016年3月至2018年3月河北胸科医院呼吸二科住院部收治的COPD患者200例(研究组,治疗有效组124例和治... 目的探讨呼出气一氧化氮(FENO)及嗜酸粒细胞(EOS)预测慢性阻塞性肺疾病(COPD)患者吸入型糖皮质激素(ICS)治疗效果的临床价值。方法选取2016年3月至2018年3月河北胸科医院呼吸二科住院部收治的COPD患者200例(研究组,治疗有效组124例和治疗无效组76例)和健康体检者80例(对照组),组间比较FENO、EOS值的差异,采用受试者工作特征(ROC)曲线分析FENO水平对COPD患者ICS治疗效果的预测价值。结果治疗前后,研究组FENO、EOS值明显高于对照组.研究组治疗后FENO、EOS值明显低于治疗前(P<0.05)。治疗前,治疗有效组和治疗无效组FENO, EOS值比较差异无统计学意义(P >0.05),治疗后,治疗有效组和治疗无效组FENO、EOS值明显低于治疗前,治疗有效组FENO、EOS值明显低于治疗无效组(P<0.05)。经Pearson相关性分析显示,治疗前FENO值和EOS值呈显著正相关(r=0.514, P=0.012)。治疗前FENO、EOS值预测COPD患者ICS治疗效果的ROC曲线下面积为0.721, 0.635。结论 FENO、EOS预测COPD患者ICS治疗效果的临床价值显著。 展开更多
关键词 呼出气一氧化氮 嗜酸粒细胞 肺疾病 慢性阻塞性 糖皮质激素 吸入型
原文传递
Insight into the interaction of inhaled corticosteroids with human serum albumin: A spectroscopic-based study 被引量:2
20
作者 Carlotta Pontremoli Nadia Barbero +1 位作者 Guido Viscardi Sonja Visentin 《Journal of Pharmaceutical Analysis》 SCIE CAS CSCD 2018年第1期37-44,共8页
It is well known that the safety and efficacy profile of an inhaled cortocosteroid(ICS) is influenced by the pharmacokinetic properties and associated pharmacodynamic effects of the drug. Freely circulating,protein un... It is well known that the safety and efficacy profile of an inhaled cortocosteroid(ICS) is influenced by the pharmacokinetic properties and associated pharmacodynamic effects of the drug. Freely circulating,protein unbound, and active ICS can cause systemic adverse effects. Therefore, a detailed investigation of drug-protein interaction could be of great interest to understand the pharmacokinetic behaviour of corticosteroids and for the design of new analogues with effective pharmacological properties. In the present work, the interaction between some corticosteroids and human serum albumin(HSA) has been studied by spectroscopic approaches. UV–Vis spectroscopy confirmed that all the investigated corticosteroids can bind to HSA forming a protein-drug complex. The intrinsic fluorescence of HSA was quenched by all the investigated drugs, which was rationalized in terms of a static quenching mechanism. The thermodynamic parameters determined by the Van't Hoff analysis of the binding constants(negative ΔH and ΔS values) clearly indicate thathydrogen bonds and van der Waals forces play a major role in the binding process between albumin and betamethasone, flunisolide and prednisolone, while hydrophobic forces may play a major role in stabilizing albumin-triamcinolone complexes. 展开更多
关键词 Human serum ALBUMIN inhaled CORTICOSTEROIDS FLUORESCENCE spectroscopy FLUORESCENCE resonance energy transfer(FRET)
下载PDF
上一页 1 2 250 下一页 到第
使用帮助 返回顶部